RxDoctor Payments Data

Frederick Dressler, MD

Internal Medicine · Sylva, NCNPI 1669451233

Payments from drug & device makers

$551in general payments, 2019–2025

Across 33 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$146
  • Boston Scientific$78
  • Cardiovascular Systems Inc.$57
  • Lilly USA, LLC$53
  • Bayer$35
  • Corcept Therapeutics$32
  • plus $150 from 9 others

What the payments were for

  • Food & beverage$551100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$551 in reported general payments places this provider in the 65th percentile of 3,302 internal medicine providers in North Carolina.

See all internal medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$86,724
Medicare patients
330
Services billed
955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban128$110,581
XareltoRivaroxaban34$34,116
Flecainide Acetate43$1,588
Metoprolol Succinate140$1,233
Losartan Potassium69$683
Potassium Chloride80$666
Atorvastatin Calcium71$478
Lisinopril75$348
Labetalol Hcl13$313
Amlodipine Besylate53$308
Furosemide121$297
Ezetimibe14$293
Rosuvastatin Calcium24$289
ClopidogrelClopidogrel Bisulfate34$260
Digoxin15$256

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$13$110,581128 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,302 internal medicine providers in North Carolina.

Other internal medicine in Sylva

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →